FundingWatcher
Home / Startups / Top health care startups / Health care startups in Basel, Switzerland

Health care startups in Basel, Switzerland

Updated 16 Nov 2026

Reset
Health care startups in Basel, Switzerland
One-time CSV
  • 48 funded companies, 35 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care~basel-basel-stadt.csv48 rows × 18 columns
CompanyCityLast roundAmountDate
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11
Windward BioBaselSeries B$165.0M2026-05-04
Noema PharmaBaselSeries B$147.2M2024-12-11
LyfegenBaselSeries A$5.7M2024-12-11
RhygazeBaselSeries A$86.0M2025-01-10
Cimeio TherapeuticsBaselSeries A$50.0M2022-04-13
ScailyteBaselSeries A$1.8M2023-12-04
Engimmune TherapeuticsBaselSeed$15.8M2022-05-03

8 rows of the CSV in 5 of its 18 columns.

48
Startups
$2.0B
Total raised
7
Funded in the last 12 months
$494.3M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

26 of 48
26 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
Rhygaze Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. Biotech Series A $86.0M 2025-01-10 $97.3M Google Ventures, F-Prime, ARCH Venture Partners +2 11 to 50 2024
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
Lyfegen Lyfegen provides SaaS rebate management software for the healthcare industry. Fintech Series A $5.7M 2024-12-11 MassChallenge, Innosuisse, APEX Ventures +1 51 to 100 2018
Translation-X Translation-X is a spin-off project developing novel therapeutics for autism spectrum disorders. Biotech Pre-seed $177K 2024-09-30 Venture Kick 1 to 10 2022
NXI Therapeutics NXI Therapeutics develops immunosuppressive drugs for autoimmune diseases and organ transplantation. Biotech Pre-seed $4.0M 2024-06-18 $4.0M Venture Kick, Kickfund, Gebert Rüf Stiftung +1 1 to 10 2021
Myria Biosciences Myria Biosciences discovers natural product drugs using genetically engineered cells that produce them. Biotech Pre-seed $1.9M 2024-01-05 $1.9M Creator Fund 1 to 10 2022
Scailyte Scailyte delivers precision medicine through single-cell science. Artificial intelligence Series A $1.8M 2023-12-04 $15.6M Venture Kick, Verve Ventures, Innosuisse +2 11 to 50 2017
KetoSwiss KetoSwiss is a Swiss biotech startup developing ketone body products to combat diseases. Biotech Seed $800K 2023-08-04 $6.4M R42 Group, Healthspan Capital, Baszucki Group 1 to 10 2017
Versameb Versameb discovers and develops RNA-based drugs. Biotech Seed $10.0M 2023-06-14 $28.1M Bernina BioInvest 11 to 50 2017
Axom Axom automates visual inspection in healthcare using image analysis. Health care Seed $883K 2023-06-05 SICTIC, Spicehaus Partners 11 to 50 2019
Engimmune Therapeutics Engimmune Therapeutics engineers T cell receptor therapies and develops products based on its platform. Biotech Seed $15.8M 2022-05-03 Novo Holdings, Kinled Holding, Pureos Bioventures +1 11 to 50 2021
Cimeio Therapeutics Cimeio Therapeutics develops curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders. Biotech Series A $50.0M 2022-04-13 $50.0M Versant Ventures 11 to 50 2020
Stromal Therapeutics Stromal Therapeutics is a biotechnology spin-off from the Kantonsspital St.Gallen. Biotech Seed $537K 2022-01-28 BaseLaunch 1 to 10 2018
POLYNEURON Polyneuron is a pharmaceutical company developing a new drug class for autoimmune disorders. Biotech Series A $15.4M 2020-09-16 $45.0M New Enterprise Associates, Venture Kick, Sofinnova Partners +1 1 to 10 2014
deepCDR Biologics deepCDR Biologics is a biotechnology company providing scalable technologies and services. Biotech Pre-seed $41K 2020-01-21 $82K Venture Kick 1 to 10 2019
NBE-Therapeutics NBE-Therapeutics develops oncology treatments for cancer patients. Biotech Series C $22.0M 2020-01-10 $65.7M Novo Holdings, Boehringer Ingelheim Venture Fund, PPF Group 11 to 50 2012
Therachon Therachon is a global biotechnology company developing medicines for rare genetic diseases. Biotech Series B $60.0M 2018-08-09 $100.0M Bpifrance, New Enterprise Associates, OrbiMed +2 1 to 10 2014
PIQUR Therapeutics PIQUR Therapeutics is a Swiss pharmaceutical company developing anti-cancer drugs. Biotech Series A $30.9M 2017-09-01 $86.9M Venture Kick, Versant Ventures 11 to 50 2011
KORING KORING develops innovations that improve quality of life for stoma patients worldwide. Biotech Pre-seed $140K 2013-01-28 $140K Venture Kick 1 to 10 2012
Synosia Therapeutics Synosia Therapeutics develops and commercializes products for unmet needs in psychiatry and neurology. Biotech Series C $30.0M 2010-10-12 $94.0M Novo Holdings, Versant Ventures, 5AM Ventures +2 1 to 10 2006
Okairos Okairos develops genetic T-cell vaccines, including candidates targeting hepatitis C virus. Biotech Series B $20.5M 2010-09-14 $30.1M EQT Life Sciences, Versant Ventures, Novartis Venture Fund +2 1 to 10 2007
Vivendy Therapeutics Vivendy Therapeutics develops enzyme replacement therapies. Biotech Series B $30.5M 2008-06-23 EQT Life Sciences, BioMedPartners, TVM Capital +1 11 to 50 2006
4-Antibody AG 4-Antibody AG develops a human antibody drug-discovery platform for immuno-oncology therapeutics. Biotech Series A $18.4M 2007-01-16 $20.6M EQT Life Sciences, BioMedPartners, Grazia Equity +2 251 to 500 2002
Moda Technology Partners Moda Technology Partners develops commercial software. Health care Series A $2.3M 2006-07-11 Osage Venture Partners 11 to 50 2005

Table 1. Health care startups in Basel, Switzerland: the 26 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 48.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019

Table 2. Health care startups in Basel, Switzerland: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Venture Kick Startup incubator Schlieren, Switzerland 8 17%
2 Novo Holdings Corporate venture arm Hellerup, Denmark 5 10% 1 Windward Bio
3 Versant Ventures Venture capital firm Menlo Park, United States 5 10%
4 BaseLaunch Startup accelerator Allschwil, Switzerland 3 6%
5 BioMedPartners Venture capital firm Basel, Switzerland 3 6%
6 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 3 6%
7 OrbiMed Private equity firm New York, United States 2 4% 1 Windward Bio
8 Sofinnova Partners Venture capital firm Paris, France 2 4%
9 Innosuisse Government investment office Berne, Switzerland 2 4%
10 Novartis Venture Fund Corporate venture arm Basel, Switzerland 2 4%
11 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 2 4%
12 Gebert Rüf Stiftung Entrepreneurship program Basel, Switzerland 2 4%
13 New Enterprise Associates Venture capital firm Menlo Park, United States 2 4%
14 Medicxi Venture capital firm London, United Kingdom 1 2% 1 Vaderis Therapeutics
15 Blue Owl Private equity firm New York, United States 1 2% 1 Windward Bio

Table 3. Health care startups in Basel, Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 35 73% $1.9B
Software 8 17% $18.9M
Artificial intelligence 3 6% $18.9M
Fintech 1 2%
Hardware 1 2%

Table 4. Health care startups in Basel, Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 11 23% $177K
Seed 11 23% $3.5M
Series A 14 29% $15.4M
Series B 8 17% $70.0M
Series C 3 6% $22.0M
Series D+ 1 2% $134.7M

Table 5. Health care startups in Basel, Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 14% $134.7M
August 2026 1 14% $152.0M
June 2026 1 14%
May 2026 3 43% $201.9M
December 2025 1 14% $5.7M

Table 6. Health care startups in Basel, Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 6 12% $488.6M
2025 7 15% $163.7M
2024 5 10% $158.9M
2023 8 17% $48.3M
2022 3 6% $66.4M
2021 2 4% $1.2M

Table 7. Health care startups in Basel, Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 7 15%
2020 to 2022 11 23%
2015 to 2019 15 31%
2010 to 2014 9 19%
Before 2010 6 12%

Table 8. Health care startups in Basel, Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 25 52%
11 to 50 20 42%
51 to 100 2 4%
251 to 500 1 2%

Table 9. Health care startups in Basel, Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Basel, Switzerland are on the list?
48, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 48 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups in Basel, Switzerland: 48 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other sectors in Basel

Health care startups elsewhere

Cite: FundingWatcher, 48 funded health care companies in Basel, Switzerland, 16 November 2026. https://fundingwatcher.com/startups/health-care/basel-basel-stadt/